Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05790772 · ClinicalTrials.gov registry record · NA
Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers
A NA study of Hormone Disturbance and Endorphin Changes, sponsored by Touro University Nevada.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05790772 is a NA study of Hormone Disturbance and Endorphin Changes that has completed, run by Touro University Nevada. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05790772, a NA study of Hormone Disturbance and Endorphin Changes, has completed, sponsored by Touro University Nevada.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will recruit 20 male and female athletes of endurance training background. They will participate in 50 minutes of vigorous activity on a treadmill with 3 blood draws (before exercising, 50 minutes into exercising, and 30 minutes after completion of exercising). After collection of the blood samples, the results will be analyzed for extracellular vesicles and biochemical changes within said extracellular vesicles.
Conditions Studied
Interventions
- BEHAVIORAL Vigorous Exercise
Study Locations (1)
Nevada
- Touro University Nevada - Henderson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2023-07-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05790772
The ClinicalTrials.gov registry entry for NCT05790772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Touro University Nevada, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hormone Disturbance appearing as the primary indexed condition, and to 1 intervention - of which Vigorous Exercise is the first listed.
NCT05790772 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT05790772 about?
NCT05790772 is a clinical study titled "Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers". This study will recruit 20 male and female athletes of endurance training background. They will participate in 50 minutes of vigorous activity on a treadmill with 3 blood draws (before exercising, 50 minutes into exercising, and 30 minutes after completion of exercising). After collection of the blo...
What is the current status of trial NCT05790772?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-03-01. Estimated completion is 2023-07-23.
What conditions does trial NCT05790772 study?
This clinical trial studies the following conditions: Hormone Disturbance, Endorphin Changes.
What interventions are being tested in trial NCT05790772?
The interventions under investigation include: Vigorous Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05790772?
This trial is sponsored by Touro University Nevada, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05790772 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hormone Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.